News | Page 3
Daily news and information for physicians in a range of specialties and practice settings.
Consistent Condom Use Significantly Reduces Risk of New HIV Infection
Among men who have sex with men, the increased odds of a new HIV infection per HIV-positive partner was reduced by 91% for each partner with whom condoms were always used.
FDA Approves First Complete, Darunavir-Based Single Tablet for HIV
SYMTUZA has been approved by the FDA based on the data of a pair of 48-week pivotal phase 3 trials which showed the non-inferiority safety and efficacy of the drug versus a controlled regimen.
Understanding, Valuing The Medical Journey to Weight Loss
The paradigm of obesity is complex and requires a multi-disciplinary approach, but it is one of the most gratifying experiences for both the physicians and patient when they see the results of weight loss.
Uncontrolled Asthma Associated with Atrial Fibrillation Risks
Results showed that participants with doctor-diagnosed asthma had a 38% increased risk of developing AF compared to those without asthma.
Probiotic-Based Sanitation Reduces Hospital Infections Better Than Chlorine
A probiotic hygiene system resulted in a greater reduction of healthcare-associated infections and surface bacteria than chlorine-based cleansers, including a 66.6% reduction of
Teva Recalls Hypertension Drug Valsartan Due to Carcinogen Trace
Certain lots of the therapy, distributed under the Actavis label in the US, have been detected to have trace amounts of probably human carcinogen NDMA.
Ironwood Launches Phase 3 Linaclotide Trial for Patients with IBS-C
The double-blind, placebo-controlled, parallel-group study that aims to observe linaclotide 290 mcg in 600 adult patients with IBS-C in the US.
Misconceptions Exist About Clinical Evidence for Breakthrough Therapies, Examination Suggests
An examination of trials supporting the 46 therapies approved via the Breakthrough Therapy designation has shown that fewer data supports their approval than what may be believed.
Antiviral Flu Drug Baloxavir Marboxil Succeeds in Phase 3 Study
The antiviral treatment for patients at high risk of complications from influenza met the primary objective of efficacy measured by time to improvement of symptoms compared to placebo.
Vancomycin Most Cost-Effective Treatment for Recurrent C. difficile
Researchers compared the cost-effectiveness of vancomycin, fidaxomicin, and bezlotoxumab with vancomycin as treatments for treating the first recurrence of
<< Prev Page
Next Page >>
Choosing Among Antidiabetes Agents
Characterizing Dangerous, Unregulated Stem Cell Therapy for Ocular Disease
Empathy from Physicians More Likely to Result in Patient Information from Family
CANTREAT Results Show Treat-and-Extend Benefits Versus Once-Monthly for AMD
Ziv-Aflibercept Shows Stronger Visual Acuity Improvement in DME Than Bevacizumab
Affordable Care Act
PHYSICIAN'S MONEY DIGEST >
MD Magazine Resources
Terms & Conditions
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.